<code id='F43B80A37B'></code><style id='F43B80A37B'></style>
    • <acronym id='F43B80A37B'></acronym>
      <center id='F43B80A37B'><center id='F43B80A37B'><tfoot id='F43B80A37B'></tfoot></center><abbr id='F43B80A37B'><dir id='F43B80A37B'><tfoot id='F43B80A37B'></tfoot><noframes id='F43B80A37B'>

    • <optgroup id='F43B80A37B'><strike id='F43B80A37B'><sup id='F43B80A37B'></sup></strike><code id='F43B80A37B'></code></optgroup>
        1. <b id='F43B80A37B'><label id='F43B80A37B'><select id='F43B80A37B'><dt id='F43B80A37B'><span id='F43B80A37B'></span></dt></select></label></b><u id='F43B80A37B'></u>
          <i id='F43B80A37B'><strike id='F43B80A37B'><tt id='F43B80A37B'><pre id='F43B80A37B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:7197
          Boxes of Wegovy. -- health coverage from STAT
          Bloomberg

          A landmark study that found the blockbuster obesity drug Wegovy reduces the chance of heart problems adds urgency to a basic question in medicine: what exactly is the relationship between weight and health?

          On its face, the result that Wegovy cut the risk of major cardiovascular complications by 20% lends credence to arguments by drugmakers, including Wegovy manufacturer Novo Nordisk, that obesity is a disease and weight loss makes people healthier.

          advertisement

          But researchers and doctors cautioned that the results don’t prove obesity treatments improve heart health solely by helping people lose weight. It’s likely that weight loss is one cause, they said, but there could be other key mechanisms at play independent from Wegovy’s effect on body weight.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          JPM 2024: Verve Therapeutics looks to mainstream genome editing
          JPM 2024: Verve Therapeutics looks to mainstream genome editing

          VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Idaho abortion case may prompt more restrictions in other states

          DrewAngerer/GettyImagesTheU.S.SupremeCourt’sdecisiontoconsiderthelegalityofIdaho’sabortionlaw—andtor